(Q47295202)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29239040%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

review article

1 reference

title

Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29239040%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29239040%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Dario de Biase

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29239040%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

author name string

Giorgia Acquaviva

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29239040%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Michela Visani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29239040%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Andrea Repaci

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29239040%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Kerry J Rhoden

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29239040%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Annalisa Pession

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29239040%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

publication date

1 January 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29239040%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29239040%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29239040%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29239040%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

page(s)

6-31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29239040%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

cites work

Global cancer statistics

1 reference

Molecular pathogenesis and mechanisms of thyroid cancer

21 January 2018

1 reference

Increasing incidence of thyroid cancer: controversies explored

21 January 2018

1 reference

Biologic and Clinical Perspectives on Thyroid Cancer

21 January 2018

1 reference

Integrated genomic characterization of papillary thyroid carcinoma

21 January 2018

1 reference

Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer

21 January 2018

1 reference

ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer

21 January 2018

1 reference

Dietary nitrate and nitrite and the risk of thyroid cancer in the NIH-AARP Diet and Health Study

21 January 2018

1 reference

Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer.

21 January 2018

1 reference

Genetic Predisposition to Familial Nonmedullary Thyroid Cancer: An Update of Molecular Findings and State-of-the-Art Studies

21 January 2018

1 reference

Familial non-medullary thyroid cancer: unraveling the genetic maze

21 January 2018

1 reference

Understanding the relationship between age and thyroid cancer

21 January 2018

1 reference

NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.

21 January 2018

1 reference

An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer.

21 January 2018

1 reference

Morphologic characteristics of Chernobyl-related childhood papillary thyroid carcinomas are independent of radiation exposure but vary with iodine intake

21 January 2018

1 reference

The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations

21 January 2018

1 reference

Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations

21 January 2018

1 reference

Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.

21 January 2018

1 reference

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.

21 January 2018

1 reference

Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence

21 January 2018

1 reference

Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules

21 January 2018

1 reference

Preoperative diagnosis of benign thyroid nodules with indeterminate cytology

21 January 2018

1 reference

Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer

21 January 2018

1 reference

Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay.

21 January 2018

1 reference

MicroRNA Expression and Association with Clinicopathologic Features in Papillary Thyroid Cancer: A Systematic Review.

21 January 2018

1 reference

Follicular adenoma and carcinoma of the thyroid gland

21 January 2018

1 reference

Benign thyroid nodules with RAS mutation grow faster.

21 January 2018

1 reference

Molecular genetics and diagnosis of thyroid cancer

21 January 2018

1 reference

Thyroid gland clonality revisited: the embryonal patch size of the normal human thyroid gland is very large, suggesting X-chromosome inactivation tumor clonality studies of thyroid tumors have to be interpreted with caution

21 January 2018

1 reference

N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation to thyroglobulin expression.

21 January 2018

1 reference

PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]

21 January 2018

1 reference

ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.

21 January 2018

1 reference

RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.

21 January 2018

1 reference

PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.

21 January 2018

1 reference

Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma.

21 January 2018

1 reference

CREB3L2-PPARgamma fusion mutation identifies a thyroid signaling pathway regulated by intramembrane proteolysis.

21 January 2018

1 reference

RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact.

21 January 2018

1 reference

Evaluation of the PAX8/PPARG translocation in follicular thyroid cancer with a 4-color reverse-transcription PCR assay and automated high-resolution fragment analysis

21 January 2018

1 reference

The role of the PAX8/PPARgamma fusion oncogene in the pathogenesis of follicular thyroid cancer

21 January 2018

1 reference

NRAS codon 61 mutation is associated with distant metastasis in patients with follicular thyroid carcinoma

21 January 2018

1 reference

Identification of oncogenic mutations and gene fusions in the follicular variant of papillary thyroid carcinoma.

21 January 2018

1 reference

Immunohistochemical detection of NRAS(Q61R) protein in follicular-patterned thyroid tumors

21 January 2018

1 reference

Preoperative detection of RAS mutation may guide extent of thyroidectomy.

21 January 2018

1 reference

Prevalence and phenotypic correlations of EIF1AX mutations in thyroid nodules

21 January 2018

1 reference

TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.

21 January 2018

1 reference

TERT promoter mutations: a genetic signature of benign and malignant thyroid tumours occurring in the context of tinea capitis irradiation

21 January 2018

1 reference

Conventional and molecular cytogenetics of human non-medullary thyroid carcinoma: characterization of eight cell line models and review of the literature on clinical samples

21 January 2018

1 reference

Delineation of a 150-kb breakpoint cluster in benign thyroid tumors with 19q13.4 aberrations.

21 January 2018

1 reference

THADA fusion is a mechanism of IGF2BP3 activation and IGF1R signaling in thyroid cancer

21 January 2018

1 reference

Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas

21 January 2018

1 reference

Activating point mutations of the gsp oncogene in human thyroid adenomas

21 January 2018

1 reference

Molecular pathogenesis of euthyroid and toxic multinodular goiter

21 January 2018

1 reference

Recurrent EZH1 mutations are a second hit in autonomous thyroid adenomas

21 January 2018

1 reference

Molecular profile of hyalinizing trabecular tumours of the thyroid: high prevalence of RET/PTC rearrangements and absence of B-raf and N-ras point mutations.

21 January 2018

1 reference

Hyalinizing trabecular tumour of the thyroid-differential expression of distinct miRNAs compared with papillary thyroid carcinoma.

21 January 2018

1 reference

Pathogenetic mechanisms in thyroid follicular-cell neoplasia

21 January 2018

1 reference

Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers

21 January 2018

1 reference

Dysregulation of the phosphatidylinositol 3-kinase pathway in thyroid neoplasia

21 January 2018

1 reference

Genetic alterations in the phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer

21 January 2018

1 reference

Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome

21 January 2018

1 reference

Follicular carcinoma presenting as autonomous functioning thyroid nodule and containing an activating mutation of the TSH receptor (T620I) and a mutation of the Ki-RAS (G12C) genes.

21 January 2018

1 reference

Highly prevalent TERT promoter mutations in aggressive thyroid cancers

21 January 2018

1 reference

Frequency of TERT promoter mutations in human cancers

21 January 2018

1 reference

The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas

21 January 2018

1 reference

TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer

21 January 2018

1 reference

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas

21 January 2018

1 reference

Follicular thyroid carcinoma: chromosome analysis of 19 cases.

21 January 2018

1 reference

MECHANISMS IN ENDOCRINOLOGY: MicroRNA in diagnostics and therapy of thyroid cancer

21 January 2018

1 reference

miRNAs with the potential to distinguish follicular thyroid carcinomas from benign follicular thyroid tumors: results of a meta-analysis.

21 January 2018

1 reference

Current thyroid cancer trends in the United States

21 January 2018

1 reference

Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.

21 January 2018

1 reference

The spectrum of papillary thyroid carcinoma variants

21 January 2018

1 reference

Papillary thyroid carcinoma variants

21 January 2018

1 reference

Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors

21 January 2018

1 reference

Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations.

21 January 2018

1 reference

Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns

21 January 2018

1 reference

Sporadic ret-rearranged papillary carcinoma of the thyroid: a subset of slow growing, less aggressive thyroid neoplasms?

21 January 2018

1 reference

RET oncogene activation in papillary thyroid carcinoma.

21 January 2018

1 reference

Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer

21 January 2018

1 reference

Diffuse (or multinodular) follicular variant of papillary thyroid carcinoma: a clinicopathologic and immunohistochemical analysis of ten cases of an aggressive form of differentiated thyroid carcinoma.

21 January 2018

1 reference

RET/PTC rearrangement in thyroid tumors

21 January 2018

1 reference

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

21 January 2018

1 reference

Real-time quantitative RT-PCR identifies distinct c-RET, RET/PTC1 and RET/PTC3 expression patterns in papillary thyroid carcinoma.

21 January 2018

1 reference

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer

21 January 2018

1 reference

RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.

21 January 2018

1 reference

Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity.

21 January 2018

1 reference

BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study

21 January 2018

1 reference

BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients

21 January 2018

1 reference

Detection of BRAF mutations in thyroid nodules by allele-specific PCR using a dual priming oligonucleotide system.

21 January 2018

1 reference

Prognostic utility of BRAF mutation in papillary thyroid cancer

21 January 2018

1 reference

Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling

21 January 2018

1 reference

The Chernobyl thyroid cancer experience: pathology

21 January 2018

1 reference

Immunohistochemical detection of the BRAF V600E-mutated protein in papillary thyroid carcinoma.

21 January 2018

1 reference

Rearranged anaplastic lymphoma kinase (ALK) gene in adult-onset papillary thyroid cancer amongst atomic bomb survivors

21 January 2018

1 reference

Detection of BRAF(V600E) Mutations in Papillary Thyroid Carcinomas by Peptide Nucleic Acid Clamp Real-Time PCR: A Comparison with Direct Sequencing

21 January 2018

1 reference

BRAFV600E mutation does not mean distant metastasis in thyroid papillary carcinomas

21 January 2018

1 reference

Detection of BRAF V600E mutation with thyroid tissue using pyrosequencing: comparison with PNA-clamping and real-time PCR.

21 January 2018

1 reference

Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers.

21 January 2018

1 reference

High-sensitivity BRAF mutation analysis: BRAF V600E is acquired early during tumor development but is heterogeneously distributed in a subset of papillary thyroid carcinomas.

21 January 2018

1 reference

Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer

21 January 2018

1 reference

Identification of a recurrent STRN/ALK fusion in thyroid carcinomas

21 January 2018

1 reference

BRAF V600E in papillary thyroid carcinoma is associated with increased programmed death ligand 1 expression and suppressive immune cell infiltration.

21 January 2018

1 reference

A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma

21 January 2018

1 reference

BRAF inhibitor dabrafenib in patients with metastatic BRAF-mutant thyroid cancer

21 January 2018

1 reference

Remarkable Response to Crizotinib in Woman With Anaplastic Lymphoma Kinase-Rearranged Anaplastic Thyroid Carcinoma.

21 January 2018

1 reference

The RET oncogene in papillary thyroid carcinoma

21 January 2018

1 reference

BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study.

21 January 2018

1 reference

Association between BRAF V600E mutation and recurrence of papillary thyroid cancer.

21 January 2018

1 reference

Histopathologic and Clinical Characterization of Thyroid Tumors Carrying the BRAF(K601E) Mutation.

21 January 2018

1 reference

Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial

21 January 2018

1 reference

Associations between BRAF(V600E) and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis

21 January 2018

1 reference

Detecting Gene Rearrangements in Patient Populations Through a 2-Step Diagnostic Test Comprised of Rapid IHC Enrichment Followed by Sensitive Next-Generation Sequencing

21 January 2018

1 reference

Papillary Thyroid Carcinoma With Rare Exon 15 BRAF Mutation Has Indolent Behavior: A Single-Institution Experience.

21 January 2018

1 reference

Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer

21 January 2018

1 reference

Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer.

21 January 2018

1 reference

Identification of Three Novel Fusion Oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET, in Thyroid Cancers of Young Patients in Fukushima

21 January 2018

1 reference

Exceptional Response with Immunotherapy in a Patient with Anaplastic Thyroid Cancer.

21 January 2018

1 reference

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence

21 January 2018

1 reference

TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease.

21 January 2018

1 reference

Effects of Coexistent BRAFV600E and TERT Promoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis

21 January 2018

1 reference

Prognostic value of nuclear DNA content in papillary thyroid carcinoma

21 January 2018

1 reference

Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers

21 January 2018

1 reference

Gain of 1q and loss of 9q21.3-q32 are associated with a less favorable prognosis in papillary thyroid carcinoma

21 January 2018

1 reference

Genome-wide appraisal of thyroid cancer progression.

21 January 2018

1 reference

Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker

21 January 2018

1 reference

Gain of chromosome band 7q11 in papillary thyroid carcinomas of young patients is associated with exposure to low-dose irradiation

21 January 2018

1 reference

The role of microRNA genes in papillary thyroid carcinoma

21 January 2018

1 reference

Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.

21 January 2018

1 reference

miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF(V600E) mutation.

21 January 2018

1 reference

MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma

21 January 2018

1 reference

Correlations between the expression levels of micro-RNA146b, 221, 222 and p27Kip1 protein mRNA and the clinicopathologic parameters in papillary thyroid cancers.

21 January 2018

1 reference

DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome

21 January 2018

1 reference

Quantification of Thyroid Cancer and Multinodular Goiter Risk in the DICER1 Syndrome: A Family-Based Cohort Study

21 January 2018

1 reference

Dicer expression and microRNA dysregulation associate with aggressive features in thyroid cancer

21 January 2018

1 reference

A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]

21 January 2018

1 reference

Molecular features of thyroid oncocytic tumors

21 January 2018

1 reference

Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy

21 January 2018

1 reference

A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors.

21 January 2018

1 reference

Chromosomal aberrations by comparative genomic hybridization in hürthle cell thyroid carcinomas are associated with tumor recurrence

21 January 2018

1 reference

Aneuploidy in oncocytic lesions of the thyroid gland: diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations.

21 January 2018

1 reference

Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors

21 January 2018

1 reference

Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors.

21 January 2018

1 reference

The biology and the genetics of Hurthle cell tumors of the thyroid.

21 January 2018

1 reference

Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III.

21 January 2018

1 reference

Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma

21 January 2018

1 reference

Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid.

21 January 2018

1 reference

A mutation threshold distinguishes the antitumorigenic effects of the mitochondrial gene MTND1, an oncojanus function.

21 January 2018

1 reference

Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach

21 January 2018

1 reference

Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression.

21 January 2018

1 reference

Outcomes in patients with poorly differentiated thyroid carcinoma

21 January 2018

1 reference

Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland

21 January 2018

1 reference

High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas

21 January 2018

1 reference

Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors

21 January 2018

1 reference

Mutation of the PIK3CA gene in anaplastic thyroid cancer.

21 January 2018

1 reference

The first 30 years of p53: growing ever more complex

21 January 2018

1 reference

Genetic alterations in the phosphoinositide 3-kinase/Akt signaling pathway confer sensitivity of thyroid cancer cells to therapeutic targeting of Akt and mammalian target of rapamycin

21 January 2018

1 reference

The Akt-specific inhibitor MK2206 selectively inhibits thyroid cancer cells harboring mutations that can activate the PI3K/Akt pathway

21 January 2018

1 reference

Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.

21 January 2018

1 reference

Cell cycle deregulation and TP53 and RAS mutations are major events in poorly differentiated and undifferentiated thyroid carcinomas

21 January 2018

1 reference

Response and acquired resistance to everolimus in anaplastic thyroid cancer

21 January 2018

1 reference

Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis

21 January 2018

1 reference

Specific microRNAs are downregulated in human thyroid anaplastic carcinomas.

21 January 2018

1 reference

MicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insights

21 January 2018

1 reference

Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors

21 January 2018

1 reference

Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients.

21 January 2018

1 reference

Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing

21 January 2018

1 reference

Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective Study

21 January 2018

1 reference

Comprehensive screening for PD-L1 expression in thyroid cancer.

21 January 2018

1 reference

miRNA expression in anaplastic thyroid carcinomas

21 January 2018

1 reference

Encapsulated well-differentiated follicular-patterned thyroid carcinomas do not play a significant role in the fatality rates from thyroid carcinoma

21 January 2018

1 reference

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

21 January 2018

1 reference

Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.

21 January 2018

1 reference

Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer

21 January 2018

1 reference

BRAF V600E inhibition in anaplastic thyroid cancer.

21 January 2018

1 reference

Response to Targeted Therapy in BRAF Mutant Anaplastic Thyroid Cancer.

21 January 2018

1 reference

Molecular pathways: adaptive kinome reprogramming in response to targeted inhibition of the BRAF-MEK-ERK pathway in cancer

21 January 2018

1 reference

Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer.

21 January 2018

1 reference

Clonality of thyroid nodules in sporadic goiter

21 January 2018

1 reference

Correlation Between Genetic Alterations and Microscopic Features, Clinical Manifestations, and Prognostic Characteristics of Thyroid Papillary Carcinomas

21 January 2018

1 reference

Whole-genome Sequencing of an Aggressive BRAF Wild-type Papillary Thyroid Cancer Identified EML4–ALK Translocation as a Therapeutic Target

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HIS.13380

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29239040%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

1 reference